Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 89

    1.

    A screen for germline mutations in the gene encoding CCCTC-binding factor (CTCF) in familial non-BRCA1/BRCA2 breast cancer.

    Zhou XL, Werelius B, Lindblom A.

    Breast Cancer Res. 2004;6(3):R187-90. Epub 2004 Mar 9.

    PMID:
    15084242
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.

    Durocher F, Labrie Y, Soucy P, Sinilnikova O, Labuda D, Bessette P, Chiquette J, Laframboise R, Lépine J, Lespérance B, Ouellette G, Pichette R, Plante M, Tavtigian SV, Simard J.

    BMC Cancer. 2006 Sep 29;6:230.

    PMID:
    17010193
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    3.

    Germline RAP80 mutations and susceptibility to breast cancer.

    Akbari MR, Ghadirian P, Robidoux A, Foumani M, Sun Y, Royer R, Zandvakili I, Lynch H, Narod SA.

    Breast Cancer Res Treat. 2009 Jan;113(2):377-81. Epub 2008 Feb 28.

    PMID:
    18306035
    [PubMed - indexed for MEDLINE]
    4.

    Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.

    Hedau S, Jain N, Husain SA, Mandal AK, Ray G, Shahid M, Kant R, Gupta V, Shukla NK, Deo SS, Das BC.

    Breast Cancer Res Treat. 2004 Nov;88(2):177-86.

    PMID:
    15564800
    [PubMed - indexed for MEDLINE]
    5.

    Germline mutations in the PTEN gene in Israeli patients with Bannayan-Riley-Ruvalcaba syndrome and women with familial breast cancer.

    Figer A, Kaplan A, Frydman M, Lev D, Paswell J, Papa MZ, Goldman B, Friedman E.

    Clin Genet. 2002 Oct;62(4):298-302.

    PMID:
    12372056
    [PubMed - indexed for MEDLINE]
    6.

    Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India.

    Saxena S, Chakraborty A, Kaushal M, Kotwal S, Bhatanager D, Mohil RS, Chintamani C, Aggarwal AK, Sharma VK, Sharma PC, Lenoir G, Goldgar DE, Szabo CI.

    BMC Med Genet. 2006 Oct 4;7:75.

    PMID:
    17018160
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    7.

    Genetic variants and haplotype analyses of the ZBRK1/ZNF350 gene in high-risk non BRCA1/2 French Canadian breast and ovarian cancer families.

    Desjardins S, Belleau P, Labrie Y, Ouellette G, Bessette P, Chiquette J, Laframboise R, Lépine J, Lespérance B, Pichette R, Plante M; INHERIT BRCAs, Durocher F.

    Int J Cancer. 2008 Jan 1;122(1):108-16.

    PMID:
    17764113
    [PubMed - indexed for MEDLINE]
    8.

    Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer.

    Lewis AG, Flanagan J, Marsh A, Pupo GM, Mann G, Spurdle AB, Lindeman GJ, Visvader JE, Brown MA, Chenevix-Trench G; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer.

    Breast Cancer Res. 2005;7(6):R1005-16. Epub 2005 Oct 21.

    PMID:
    16280053
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    9.

    BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models.

    Capalbo C, Ricevuto E, Vestri A, Ristori E, Sidoni T, Buffone O, Adamo B, Cortesi E, Marchetti P, Scambia G, Tomao S, Rinaldi C, Zani M, Ferraro S, Frati L, Screpanti I, Gulino A, Giannini G.

    Ann Oncol. 2006 Jun;17 Suppl 7:vii34-40.

    PMID:
    16760289
    [PubMed - indexed for MEDLINE]
    Free Article
    10.

    The BARD1 Cys557Ser variant and breast cancer risk in Iceland.

    Stacey SN, Sulem P, Johannsson OT, Helgason A, Gudmundsson J, Kostic JP, Kristjansson K, Jonsdottir T, Sigurdsson H, Hrafnkelsson J, Johannsson J, Sveinsson T, Myrdal G, Grimsson HN, Bergthorsson JT, Amundadottir LT, Gulcher JR, Thorsteinsdottir U, Kong A, Stefansson K.

    PLoS Med. 2006 Jul;3(7):e217.

    PMID:
    16768547
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    11.

    Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.

    Cao AY, Huang J, Hu Z, Li WF, Ma ZL, Tang LL, Zhang B, Su FX, Zhou J, Di GH, Shen KW, Wu J, Lu JS, Luo JM, Yuan WT, Shen ZZ, Huang W, Shao ZM.

    Breast Cancer Res Treat. 2009 May;115(1):51-5. Epub 2008 May 16.

    PMID:
    18483852
    [PubMed - indexed for MEDLINE]
    12.

    Expression of the transcription factor CTCF in invasive breast cancer: a candidate gene located at 16q22.1.

    Rakha EA, Pinder SE, Paish CE, Ellis IO.

    Br J Cancer. 2004 Oct 18;91(8):1591-6.

    PMID:
    15354217
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    13.

    BRCA1 and BRCA2 germline mutation analysis among Indian women from south India: identification of four novel mutations and high-frequency occurrence of 185delAG mutation.

    Vaidyanathan K, Lakhotia S, Ravishankar HM, Tabassum U, Mukherjee G, Somasundaram K.

    J Biosci. 2009 Sep;34(3):415-22.

    PMID:
    19805903
    [PubMed - indexed for MEDLINE]
    Free Article
    14.

    Comprehensive analysis of NuMA variation in breast cancer.

    Kilpivaara O, Rantanen M, Tamminen A, Aittomäki K, Blomqvist C, Nevanlinna H.

    BMC Cancer. 2008 Mar 10;8:71.

    PMID:
    18331640
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    15.

    Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients.

    Rashid MU, Zaidi A, Torres D, Sultan F, Benner A, Naqvi B, Shakoori AR, Seidel-Renkert A, Farooq H, Narod S, Amin A, Hamann U.

    Int J Cancer. 2006 Dec 15;119(12):2832-9.

    PMID:
    16998791
    [PubMed - indexed for MEDLINE]
    16.

    Mutation analysis of BRCA1 and BRCA2 genes in Iranian high risk breast cancer families.

    Pietschmann A, Mehdipour P, Mehdipour P, Atri M, Hofmann W, Hosseini-Asl SS, Scherneck S, Mundlos S, Peters H.

    J Cancer Res Clin Oncol. 2005 Aug;131(8):552-8. Epub 2005 May 26.

    PMID:
    15918047
    [PubMed - indexed for MEDLINE]
    17.

    Family history of cancer and germline BRCA2 mutations in sporadic exocrine pancreatic cancer.

    Real FX, Malats N, Lesca G, Porta M, Chopin S, Lenoir GM, Sinilnikova O; PANKRAS II Study Group.

    Gut. 2002 May;50(5):653-7.

    PMID:
    11950811
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    18.

    Loss of expression of chromosome 16q genes DPEP1 and CTCF in lobular carcinoma in situ of the breast.

    Green AR, Krivinskas S, Young P, Rakha EA, Paish EC, Powe DG, Ellis IO.

    Breast Cancer Res Treat. 2009 Jan;113(1):59-66. Epub 2008 Jan 23.

    PMID:
    18213475
    [PubMed - indexed for MEDLINE]
    19.

    The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.

    Cao AY, Huang J, Hu Z, Li WF, Ma ZL, Tang LL, Zhang B, Su FX, Zhou J, Di GH, Shen KW, Wu J, Lu JS, Luo JM, Yuan WT, Shen ZZ, Huang W, Shao ZM.

    Breast Cancer Res Treat. 2009 Apr;114(3):457-62. Epub 2008 Apr 30.

    PMID:
    18446436
    [PubMed - indexed for MEDLINE]
    20.

    BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer.

    Seo JH, Cho DY, Ahn SH, Yoon KS, Kang CS, Cho HM, Lee HS, Choe JJ, Choi CW, Kim BS, Shin SW, Kim YH, Kim JS, Son GS, Lee JB, Koo BH.

    Hum Mutat. 2004 Oct;24(4):350.

    PMID:
    15365993
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk